Prediction of leukemic relapse soon after bone marrow transplantation
Tratkiewicz, J.A.; Szer, J.
Transplantation Proceedings 19(1 Part 3): 2648-2650
1987
ISSN/ISBN: 0041-1345 PMID: 3274575 Document Number: 286429
Document emailed within 1 workday
Related Documents
de Gast, G.C.; Beatty, P.G.; Amos, D.; Sullivan, K.; Anderson, J.E.; Thomas, E.D.; Hansen, J.A. 1987: Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation Transplantation Proceedings 19(1 Pt 3): 2700Huang, X.; Guo, N.; Ren, H.; Zhang, Y.; Gao, Z.; Lu, D. 2003: An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation Chinese Medical Journal 116(5): 736-741
Nakayama, H.; Okamura, J.; Ikuno, Y.; Shigeno, K.; Tasaka, H. 1992: Isolated renal relapse after bone marrow transplantation in childhood leukemia. Bone Marrow Transplantation Team Bone Marrow Transplantation 10(2): 195
Richard, C.; Baro, J.; Bello-Fernandez, C.; Hermida, G.; Calavia, J.; Olalla, I.; Alsar, M.J.; Loyola, I.; Cuadrado, M.A.; Iriondo, A. 1995: Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse Bone Marrow Transplantation 15(5): 721-726
Raemaekers, J.; De Witte, T.; Schattenberg, A.; Van der Lely, N. 1989: Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines Bone Marrow Transplantation 4(2): 167-171
Zwaan, F.E.; Hermans, J. 1990: Acute lymphoblastic leukemia; factors influencing relapse after allogeneic bone marrow transplantation Bone Marrow Transplantation 6(Suppl 1): 71
Browne, P.V.; Lawler, M.; O'Riordan, J.; Humphries, P.; McCann, S.R. 1991: Early detection of leukaemic relapse after bone marrow transplantation using the polymerase chain reaction Bone Marrow Transplantation 7(2): 167-169
Fraschini, D.; Uderzo, C.; Rovelli, A.; Bonomi, M.; Balduzzi, A.; Adamoli, L.; Locasciulli, A.; Pignanelli, M.; Tagliabue, R.; Ebanista, P. 1991: Oral and dental status in leukemic children treated with bone marrow transplantation Bone Marrow Transplantation 8(Suppl 1): 64-65
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Kodera, Y.; Yamada, H.; Morishima, Y.; Ohno, R.; Yoshikawa, S.; Yamada, K. 1986: Influence of pretransplant clinical conditions on the prognosis of patients treated with allogeneic bone marrow transplantation during leukemia relapse Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 49(1): 86-92
Soiffer, R.J.; Roy, D.C.; Gonin, R.; Murray, C.; Anderson, K.C.; Freedman, A.S.; Rabinowe, S.N.; Robertson, M.J.; Spector, N.; Pesek, K. 1993: Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse Bone Marrow Transplantation 12(3): 243-251
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Porter, D.L.; Roth, M.S.; Lee, S.J.; McGarigle, C.; Ferrara, J.L.; Antin, J.H. 1996: Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation Bone Marrow Transplantation 18(5): 975-980
Schmid, H.; von Schenck, U.; Hartmann, R.; Borgmann, A.; Henze, G. 1996: Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group Bone Marrow Transplantation 18(Suppl 2): 28-30
Hurley, R.; Weisdorf, D.J.; Jessurun, J.; Vercellotti, G.M.; Miller, W.J. 1992: Relapse of acute leukemia presenting as acute cholecystitis following bone marrow transplantation Bone Marrow Transplantation 10(4): 387-389
León-Rodríguez, E.; Sosa Sánchez, R.; Gómez, E.; Ochoa Sosa, C. 1993: Bone marrow transplantation in aplastic anemia. Experience at a Mexican institution. Bone marrow transplantation group of the Salvador Zubirán National Institute of Nutrition Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 45(6): 559-564
Gassmann, W.; von Kolszynski, M.; Wottge, H.U.; Müller-Ruchholtz, W. 1987: Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation Transplantation Proceedings 19(1 Part 3): 2687-2688
Moussalem, M.; Esperou Bourdeau, H.; Devergie, A.; Baruchel, A.; Ribaud, P.; Socie, G.; Parquet, N.; Traineau, R.; Hirsch, I.; Schaison, G. 1995: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplantation 15(6): 943-947
Sica, S.; Di Mario, A.; Salutari, P.; Rutella, S.; Chiusolo, P.; Rumi, C.; Menichella, G.; D'Onofrio, G.; Leone, G. 1995: Chemotherapy and recombinant human granulocyte colony-stimulating factor primed donor leukocyte infusion for treatment of relapse after allogeneic bone marrow transplantation Bone Marrow Transplantation 16(3): 483-485